Literature DB >> 7998962

Constitutive nuclear NF-kappa B in cells of the monocyte lineage.

M Frankenberger1, A Pforte, T Sternsdorf, B Passlick, P A Baeuerle, H W Ziegler-Heitbrock.   

Abstract

In monocytes, the nuclear factor NF-kappa B has been invoked as an important transcription factor in the expression of cytokine genes, of cell-surface receptors and in the expression of human immunodeficiency virus. In such cells, DNA binding activity of NF-kappa B can be detected without intentional stimulation. In our studies, cells of the human monocytic line Mono Mac 6, cultured in medium containing fetal-calf serum and low levels of lipopolysaccharide (LPS), also exhibit such 'constitutive' NF-kappa B, as demonstrated by mobility-shift analysis of nuclear extracts. This nuclear NF-kappa B was still present when contaminant LPS was removed by ultrafiltration and when serum was omitted. Protein-DNA complexes of constitutive NF-kappa B are similar in mobility to the LPS-induced NF-kappa B and both are recognized by an antibody specific to the p50 subunit of NF-kappa B. By contrast, treatment of cells with pyrrolidine dithiocarbamate (PDTC) will only block LPS-induced NF-kappa B, but not the constitutive binding protein. Using LPS-free and serum-free conditions, constitutive NF-kappa B can be detected in different cell lines of the monocytic lineage (HL60, U937, THP-1, Mono Mac 1 and Mono Mac 6), but not in Molt 4 T cells or K562 stem cells. When ordered according to stage of maturation, the amount of constitutive NF-kappa B was not increased in more mature cell lines. Furthermore, when inducing differentiation in Mono Mac 6 cells, with vitamin D3, no change in constitutive or inducible NF-kappa B can be detected. Analysis of primary cells revealed substantial constitutive NF-kappa B-binding activity in blood monocytes, pleural macrophages and alveolar macrophages. The constitutive NF-kappa B appears to be functionally active, since a low level of tumour necrosis factor (TNF) transcript is detectable in monocytes, and this level can be increased by blocking transcript degradation using cycloheximide. The level of constitutive NF-kappa B in these cells is variable and is frequently found to be lower in the more mature macrophages. Constitutive NF-kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor, since neutralizing antibodies did not reduce constitutive DNA-binding activity. Furthermore, blockade of prostaglandin or leukotriene biosynthesis did not affect constitutive NF-kappa B.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998962      PMCID: PMC1137456          DOI: 10.1042/bj3040087

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

Review 5.  Nuclear factor kappa B, a mediator of lipopolysaccharide effects.

Authors:  J M Müller; H W Ziegler-Heitbrock; P A Baeuerle
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

6.  Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.

Authors:  H W Ziegler-Heitbrock; T Sternsdorf; J Liese; B Belohradsky; C Weber; A Wedel; R Schreck; P Bäuerle; M Ströbel
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

7.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

Authors:  G E Nedwin; S L Naylor; A Y Sakaguchi; D Smith; J Jarrett-Nedwin; D Pennica; D V Goeddel; P W Gray
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

8.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers.

Authors:  H W Ziegler-Heitbrock; A Wedel; W Schraut; M Ströbel; P Wendelgass; T Sternsdorf; P A Bäuerle; J G Haas; G Riethmüller
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

9.  Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.

Authors:  C B Lozzio; B B Lozzio; W K Yang; A T Ichiki; E G Bamberger
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

10.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle.

Authors:  A Dugaiczyk; J A Haron; E M Stone; O E Dennison; K N Rothblum; R J Schwartz
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

View more
  28 in total

1.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

2.  Regulation of IkappaB beta in WEHI 231 mature B cells.

Authors:  R J Phillips; S Ghosh
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

3.  Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms.

Authors:  A A Baqui; T F Meiller; J J Chon; B F Turng; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation.

Authors:  Ainara Castellanos-Rubio; Radomir Kratchmarov; Maialen Sebastian; Koldo Garcia-Etxebarria; Liher Garcia; Iñaki Irastorza; Sankar Ghosh
Journal:  J Immunol       Date:  2017-06-16       Impact factor: 5.422

6.  Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity.

Authors:  C Wahl; F Oswald; U Simnacher; S Weiss; R Marre; A Essig
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins.

Authors:  S E Plevy; J H Gemberling; S Hsu; A J Dorner; S T Smale
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression.

Authors:  S Kastenbauer; H W Ziegler-Heitbrock
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation.

Authors:  Luo Zhang; Yiwu Wang; Fengjun Xiao; Shaoxia Wang; Guichun Xing; Yang Li; Xiushan Yin; Kefeng Lu; Rongfei Wei; Jiao Fan; Yuhan Chen; Tao Li; Ping Xie; Lin Yuan; Lei Song; Lanzhi Ma; Lujing Ding; Fuchu He; Lingqiang Zhang
Journal:  Cell Res       Date:  2014-04-29       Impact factor: 25.617

10.  Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide.

Authors:  S M Levitz; A Tabuni; S H Nong; D T Golenbock
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.